Investigating how Rpl5 gene changes affect blood cell production in Diamond Blackfan anemia
The role of Rpl5 haploinsufficiency in hematopoietic stem/progenitor cell function in Diamond Blackfan anemia
This study is looking at how a specific gene called Rpl5 affects blood cell production in children with Diamond Blackfan anemia, aiming to find out why some kids experience unexpected improvements and how we can create better treatments for them.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11044152 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of the Rpl5 gene in blood cell production, particularly in children with Diamond Blackfan anemia (DBA). The study aims to explore how genetic defects in ribosomal proteins can lead to severe anemia and how these defects affect hematopoietic stem and progenitor cells. By using both animal models and patient data, the research seeks to uncover the mechanisms behind spontaneous remission in DBA, which could lead to improved therapies. The principal investigator is a pediatric hematologist/oncologist dedicated to advancing treatment options for patients with various types of anemia.
Who could benefit from this research
Good fit: Ideal candidates for this research include children diagnosed with Diamond Blackfan anemia or other related blood disorders.
Not a fit: Patients with anemia not related to genetic defects in ribosomal proteins may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that improve blood cell production and reduce the need for chronic blood transfusions in patients with Diamond Blackfan anemia.
How similar studies have performed: Previous research has shown promising results in understanding genetic factors affecting anemia, but this specific approach to Rpl5 haploinsufficiency in DBA is relatively novel.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Singh, Sharon a — University of Michigan at Ann Arbor
- Study coordinator: Singh, Sharon a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.